Clinical Trials Browser

Phase EARLY_PHASE1 × durvalumab × Lymphoid × Clear all

NCT03235869 2018-03-15

Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma

Phase EARLY_PHASE1 Withdrawn

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous